Topic

Arcalyst (rilonacept)

A collection of 23 issues

How to Get Arcalyst (Rilonacept) Covered by UnitedHealthcare in Florida: Complete Prior Authorization and Appeals Guide

Quick Answer: Getting Arcalyst Approved by UnitedHealthcare in Florida UnitedHealthcare requires prior authorization for Arcalyst (rilonacept) with 12-month approvals based on FDA indications: CAPS, DIRA, or recurrent pericarditis. Submit PA forms via the provider portal with specialist notes, diagnosis confirmation (ICD-10 codes), and clinical documentation. If denied, you have 180
5 min read

Myths vs. Facts: Getting Arcalyst (rilonacept) Covered by Cigna in Michigan (2025 Appeal Guide)

Quick Answer: Arcalyst (rilonacept) Coverage by Cigna in Michigan Arcalyst requires prior authorization from Cigna for CAPS, DIRA, or recurrent pericarditis. Coverage depends on specialist prescription, documented prior therapy failures (colchicine, NSAIDs, steroids), and medical necessity documentation. If denied, Michigan residents have 180 days for internal appeals and 127 days
5 min read

Do You Qualify for Arcalyst (rilonacept) Coverage by UnitedHealthcare in California? Decision Tree & Next Steps

Quick Answer: If you have CAPS, DIRA, or recurrent pericarditis and have failed colchicine/NSAIDs, you likely qualify for Arcalyst coverage through UnitedHealthcare in California. Submit prior authorization through your specialist with documented treatment failures. If denied, California's strong Independent Medical Review process overturns ~68% of specialty drug
4 min read

How to Get Arcalyst (rilonacept) Covered by Aetna in New Jersey: Complete Prior Authorization and Appeals Guide

Answer Box: Getting Arcalyst Covered by Aetna in New Jersey Fastest path to approval: Submit prior authorization through Availity provider portal with complete documentation including specialist consultation, prior therapy failures, and elevated inflammatory markers. Standard decisions take 45 business days; expedited reviews complete within 72 hours for urgent cases. If
6 min read